EP3125894
FORLYF HIV BAKRITAHEMLA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.3.2015EP published:
9.9.2020EP application number:
15774282.6
EP translation filed:
6.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
26.3.2035Expiry date:
26.3.2027Next due date:
31.3.2027
Title:
PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS
Timeline
Today
27.3.2015EP application
9.9.2020EP Publication
6.11.2020Translation submitted
15.12.2020Registration published
26.3.2027Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
BURGEY, Christopher, S.Address:
West Point, Pennsylvania 19486, US
Name:
FRITZEN, Jeffrey, F.Address:
Pottstown, Pennsylvania 19464, US
Name:
BALSELLS, JaumeAddress:
West Point, Pennsylvania 19486, US
Name:
PATEL, MehulAddress:
West Point, Pennsylvania 19486, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201461973689 PDate:
1.4.2014Country:
US
Classification
Categories:
A61K 31/501, A61K 31/506, A61K 31/513, A61P 31/18, C07D 403/06, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.2.2021
Expires: 26.3.2022
Payer: Örn Þór slf.
Number: 8
Paid: 15.2.2022
Expires: 26.3.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.2.2023
Expires: 26.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.2.2024
Expires: 26.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.1.2025
Expires: 26.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.3.2026
Expires: 26.3.2027
Payer: Árnason Faktor ehf.